ANGIE GUERRERO: Open Payments
NPI 1588347165 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,000 in 164 payments from 17 companies in 2025. Trend: 2023 $748 · 2024 $2,057 · 2025 $3,000
Food & beverage: $3,000
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 36 | $695 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $433 |
| Lilly USA, LLC | 19 | $402 |
| ABBVIE INC. | 40 | $374 |
| AstraZeneca Pharmaceuticals LP | 11 | $215 |
| PFIZER INC. | 8 | $167 |
| Sumitomo Pharma America, Inc. | 8 | $163 |
| Phathom Pharmaceuticals, Inc. | 4 | $108 |
| Nalu Medical, Inc. | 1 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
Products named: Ozempic, Kerendia, MOUNJARO, FARXIGA, GEMTESA, QULIPTA, NURTEC ODT, KISUNLA.
Industry payments across TX — which companies pay providers there.
